Silo Pharma (SILO) Gross Margin (2019 - 2025)
Historic Gross Margin for Silo Pharma (SILO) over the last 7 years, with Q3 2025 value amounting to 14.77%.
- Silo Pharma's Gross Margin fell 1066700.0% to 14.77% in Q3 2025 from the same period last year, while for Sep 2025 it was 65.24%, marking a year-over-year decrease of 266700.0%. This contributed to the annual value of 91.9% for FY2024, which is 0.0% changed from last year.
- Latest data reveals that Silo Pharma reported Gross Margin of 14.77% as of Q3 2025, which was down 1066700.0% from 91.91% recorded in Q2 2025.
- Silo Pharma's 5-year Gross Margin high stood at 91.91% for Q2 2022, and its period low was 10101.22% during Q4 2021.
- Its 5-year average for Gross Margin is 645.93%, with a median of 91.9% in 2022.
- Its Gross Margin has fluctuated over the past 5 years, first plummeted by -95447700bps in 2021, then surged by 101931200bps in 2022.
- Over the past 5 years, Silo Pharma's Gross Margin (Quarter) stood at 10101.22% in 2021, then surged by 101bps to 91.9% in 2022, then changed by 0bps to 91.9% in 2023, then changed by 0bps to 91.9% in 2024, then crashed by -116bps to 14.77% in 2025.
- Its Gross Margin stands at 14.77% for Q3 2025, versus 91.91% for Q2 2025 and 91.9% for Q1 2025.